Delivery of RNA interference therapeutics using polycation-based nanoparticles

Advanced Drug Delivery Reviews

Volumn 61, Issue 9, 2009, Pages 710-720

  Howard, Kenneth Alan ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Bioresponsive; Extracellular; In vivo; Intracellular; Intravenous; Nanoparticles; Polycations; Polyplexes; RNA interference; siRNA

Indexed keywords

BIORESPONSIVE; EXTRACELLULAR; IN VIVO; INTRACELLULAR; INTRAVENOUS; POLYCATIONS; POLYPLEXES; RNA INTERFERENCE; SIRNA;

LIGANDS; MOLECULES; NANOPARTICLES; NUCLEIC ACIDS; RNA;

ENZYME ACTIVITY;

ATELOCOLLAGEN; CHITOSAN; CYCLODEXTRIN; MACROGOL; NANOPARTICLE; POLYCATION; POLYETHYLENEIMINE; PROTAMINE; SMALL INTERFERING RNA; TRANSFERRIN;

CELL MIGRATION; DRUG ACTIVITY; DRUG DISTRIBUTION; GENE DELIVERY SYSTEM; GENE SILENCING; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA INTERFERENCE;

ANIMALS; BIOLOGICAL TRANSPORT; GENE SILENCING; HUMANS; INJECTIONS; NANOPARTICLES; POLYAMINES; POLYETHYLENE GLYCOLS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 67349242729     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2009.04.001     Document Type: Review

References (103)

1. Behlke M.A. Progress towards in vivo use of siRNAs. Mol. Ther. 13 (2006) 644-670
2. Xie F.Y., Woodle M.C., and Lu P.Y. Harnessing in vivo siRNA delivery for drug discovery and therapeutic development. Drug Discov. Today 11 (2006) 67-73
3. De Fougerolles A., Vornlocher H.P., Maraganore J., and Lieberman J. Interfering with disease: a progress report on siRNA-based therapeutics. Nat. Rev. Drug. Discov. 6 (2007) 443-453
4. Pouton C.W., and Seymour L.W. Key issues in non-viral gene delivery. Adv. Drug Deliv. Rev. 46 (2001) 187-203
5. Howard K.A., and Kjems J. Polycation-based nanoparticle delivery for improved RNA interference therapeutics. Expert Opin. Biol. Ther. 7 (2007) 1811-1822
6. Pille J.Y., Li H., Blot E., Bertrand J.R., Pritchard L.L., Opolon P., Maksimenko A., Lu H., Vannier J.P., Soria J., Malvy C., and Soria C. Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer. Hum. Gene Ther. 17 (2006) 1019-1026
7. Elouahabi A., and Ruysschaert J.M. Formation and intracellular trafficking of lipoplexes and polyplexes. Mol. Ther. 11 (2005) 336-347
8. Torchilin V.P. Drug targeting. Eur. J. Pharm. Sci. 11 Suppl. 2 (2000) S81-91
9. Liu X., Howard K.A., Dong M., Andersen M.O., Rahbek U.L., Johnsen M.G., Hansen O.C., Besenbacher F., and Kjems J. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing. Biomaterials 28 (2007) 1280-1288
10. Koping-Hoggard M., Mel'nikova Y.S., Varum K.M., Lindman B., and Artursson P. Relationship between the physical shape and the efficiency of oligomeric chitosan as a gene delivery system in vitro and in vivo. J. Gene Med. 5 (2003) 130-141
11. Koping-Hoggard M., Varum K.M., Issa M., Danielsen S., Christensen B.E., Stokke B.T., and Artursson P. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene. Ther. 11 (2004) 1441-1452
12. Shen X.C., Zhou J., Liu X., Wu J., Qu F., Zhang Z.L., Pang D.W., Quelever G., Zhang C.C., and Peng L. Importance of size-to-charge ratio in construction of stable and uniform nanoscale RNA/dendrimer complexes. Org. Biomol. Chem. 5 (2007) 3674-3681
13. Grayson A.C., Doody A.M., and Putnam D. Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro. Pharm. Res. 23 (2006) 1868-1876
14. Thomas M., Lu J.J., Ge Q., Zhang C., Chen J., and Klibanov A.M. Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 5679-5684
15. Howard K.A., Paludan S.R., Behlke M.A., Besenbacher F., Deleuran B., and Kjems J. Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model. Mol. Ther. 17 (2009) 162-168
16. Dash P.R., Read M.L., Fisher K.D., Howard K.A., Wolfert M., Oupicky D., Subr V., Strohalm J., Ulbrich K., and Seymour L.W. Decreased binding to proteins and cells of polymeric gene delivery vectors surface modified with a multivalent hydrophilic polymer and retargeting through attachment of transferrin. J. Biol. Chem. 275 (2000) 3793-3802
17. Owens III D.E., and Peppas N.A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 307 (2006) 93-102
18. De Wolf H.K., Snel C.J., Verbaan F.J., Schiffelers R.M., Hennink W.E., and Storm G. Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration. Int. J. Pharm. 331 (2007) 167-175
19. Takeshita F., Minakuchi Y., Nagahara S., Honma K., Sasaki H., Hirai K., Teratani T., Namatame N., Yamamoto Y., Hanai K., Kato T., Sano A., and Ochiya T. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 12177-12182
20. Hwang H.Y., Kim I.S., Kwon I.C., and Kim Y.H. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. J. Control. Release 128 (2008) 23-31
21. Mao H.Q., Roy K., Troung-Le V.L., Janes K.A., Lin K.Y., Wang Y., August J.T., and Leong K.W. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J. Control. Release 70 (2001) 399-421
22. Schiffelers R.M., Ansari A., Xu J., Zhou Q., Tang Q., Storm G., Molema G., Lu P.Y., Scaria P.V., and Woodle M.C. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res. 32 (2004) e149
23. Kim S.H., Jeong J.H., Lee S.H., Kim S.W., and Park T.G. Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer. J. Control. Release 129 (2008) 107-116
24. Hu-Lieskovan S., Heidel J.D., Bartlett D.W., Davis M.E., and Triche T.J. Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma. Cancer Res. 65 (2005) 8984-8992
25. Heidel J.D., Yu Z., Liu J.Y., Rele S.M., Liang Y., Zeidan R.K., Kornbrust D.J., and Davis M.E. Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 5715-5721
26. Bartlett D.W., and Davis M.E. Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticles. Biotechnol. Bioeng. 99 (2008) 975-985
27. Bartlett D.W., Su H., Hildebrandt I.J., Weber W.A., and Davis M.E. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 15549-15554
28. Kleinman M.E., Yamada K., Takeda A., Chandrasekaran V., Nozaki M., Baffi J.Z., Albuquerque R.J., Yamasaki S., Itaya M., Pan Y., Appukuttan B., Gibbs D., Yang Z., Kariko K., Ambati B.K., Wilgus T.A., Dipietro L.A., Sakurai E., Zhang K., Smith J.R., Taylor E.W., and Ambati J. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 452 (2008) 591-597
29. Bartlett D.W., and Davis M.E. Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles. Bioconjug. Chem. 18 (2007) 456-468
30. Takeshita F., and Ochiya T. Therapeutic potential of RNA interference against cancer. Cancer Sci. 97 (2006) 689-696
31. Kawata E., Ashihara E., Kimura S., Takenaka K., Sato K., Tanaka R., Yokota A., Kamitsuji Y., Takeuchi M., Kuroda J., Tanaka F., Yoshikawa T., and Maekawa T. Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer. Mol. Cancer Ther. 7 (2008) 2904-2912
32. Hanai K., Takeshita F., Honma K., Nagahara S., Maeda M., Minakuchi Y., Sano A., and Ochiya T. Atelocollagen-mediated systemic DDS for nucleic acid medicines. Ann. N. Y. Acad. Sci. 1082 (2006) 9-17
33. Ishimoto T., Takei Y., Yuzawa Y., Hanai K., Nagahara S., Tarumi Y., Matsuo S., and Kadomatsu K. Downregulation of monocyte chemoattractant protein-1 involving short interfering RNA attenuates hapten-induced contact hypersensitivity. Mol. Ther. 16 (2008) 387-395
34. Kinouchi N., Ohsawa Y., Ishimaru N., Ohuchi H., Sunada Y., Hayashi Y., Tanimoto Y., Moriyama K., and Noji S. Atelocollagen-mediated local and systemic applications of myostatin-targeting siRNA increase skeletal muscle mass. Gene Ther. 15 (2008) 1126-1130
35. Song E., Zhu P., Lee S.K., Chowdhury D., Kussman S., Dykxhoorn D.M., Feng Y., Palliser D., Weiner D.B., Shankar P., Marasco W.A., and Lieberman J. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat. Biotechnol. 23 (2005) 709-717
36. Peer D., Zhu P., Carman C.V., Lieberman J., and Shimaoka M. Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 4095-4100
37. Peer D., Park E.J., Morishita Y., Carman C.V., and Shimaoka M. Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target. Science 319 (2008) 627-630
38. Baigude H., Mccarroll J., Yang C.S., Swain P.M., and Rana T.M. Design and creation of new nanomaterials for therapeutic RNAi. ACS Chem. Biol. 2 (2007) 237-241
39. Soutschek J., Akinc A., Bramlage B., Charisse K., Constien R., Donoghue M., Elbashir S., Geick A., Hadwiger P., Harborth J., John M., Kesavan V., Lavine G., Pandey R.K., Racie T., Rajeev K.G., Rohl I., Toudjarska I., Wang G., Wuschko S., Bumcrot D., Koteliansky V., Limmer S., Manoharan M., and Vornlocher H.P. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432 (2004) 173-178
40. Zimmermann T.S., Lee A.C., Akinc A., Bramlage B., Bumcrot D., Fedoruk M.N., Harborth J., Heyes J.A., Jeffs L.B., John M., Judge A.D., Lam K., Mcclintock K., Nechev L.V., Palmer L.R., Racie T., Rohl I., Seiffert S., Shanmugam S., Sood V., Soutschek J., Toudjarska I., Wheat A.J., Yaworski E., Zedalis W., Koteliansky V., Manoharan M., Vornlocher H.P., and Maclachlan I. RNAi-mediated gene silencing in non-human primates. Nature 441 (2006) 111-114
41. Mori T., Murakami M., Okumura M., Kadosawa T., Uede T., and Fujinaga T. Mechanism of macrophage activation by chitin derivatives. J. Vet. Med. Sci. 67 (2005) 51-56
42. Goula D., Becker N., Lemkine G.F., Normandie P., Rodrigues J., Mantero S., Levi G., and Demeneix B.A. Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes. Gene Ther. 7 (2000) 499-504
43. Ge Q., Filip L., Bai A., Nguyen T., Eisen H.N., and Chen J. Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 8676-8681
44. Ochiya T., Nagahara S., Sano A., Itoh H., and Terada M. Biomaterials for gene delivery: atelocollagen-mediated controlled release of molecular medicines. Curr. Gene Ther. 1 (2001) 31-52
45. Minakuchi Y., Takeshita F., Kosaka N., Sasaki H., Yamamoto Y., Kouno M., Honma K., Nagahara S., Hanai K., Sano A., Kato T., Terada M., and Ochiya T. Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. Nucleic Acids Res. 32 (2004) e109
46. Yamato K., Yamada T., Kizaki M., Ui-Tei K., Natori Y., Fujino M., Nishihara T., Ikeda Y., Nasu Y., Saigo K., and Yoshinouchi M. New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer. Cancer Gene Ther. 15 (2008) 140-153
47. Iwaki K., Shibata K., Ohta M., Endo Y., Uchida H., Tominaga M., Okunaga R., Kai S., and Kitano S. A small interfering RNA targeting proteinase-activated receptor-2 is effective in suppression of tumor growth in a Panc1 xenograft model. Int. J. Cancer. 122 (2008) 658-663
48. Matoba T., Orba Y., Suzuki T., Makino Y., Shichinohe H., Kuroda S., Ochiya T., Itoh H., Tanaka S., Nagashima K., and Sawa H. An siRNA against JC virus (JCV) agnoprotein inhibits JCV infection in JCV-producing cells inoculated in nude mice. Neuropathology 28 (2008) 286-294
49. Grzelinski M., Urban-Klein B., Martens T., Lamszus K., Bakowsky U., Hobel S., Czubayko F., and Aigner A. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts. Hum. Gene Ther. 17 (2006) 751-766
50. De Martimprey H., Bertrand J.R., Fusco A., Santoro M., Couvreur P., Vauthier C., and Malvy C. siRNA nanoformulation against the ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma. Nucleic Acids Res. 36 (2008) e2
51. Wang X., Xu W., Mohapatra S., Kong X., Li X., Lockey R.F., and Mohapatra S.S. Prevention of airway inflammation with topical cream containing imiquimod and small interfering RNA for natriuretic peptide receptor. Genet. Vaccines Ther. 6 (2008) 7
52. Urban-Klein B., Werth S., Abuharbeid S., Czubayko F., and Aigner A. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene. Ther. 12 (2005) 461-466
53. Howard K.A., Dash P.R., Read M.L., Ward K., Tomkins L.M., Nazarova O., Ulbrich K., and Seymour L.W. Influence of hydrophilicity of cationic polymers on the biophysical properties of polyelectrolyte complexes formed by self-assembly with DNA. Biochim. Biophys. Acta. 1475 (2000) 245-255
54. Ikehara Y., Niwa T., Biao L., Ikehara S.K., Ohashi N., Kobayashi T., Shimizu Y., Kojima N., and Nakanishi H. A carbohydrate recognition-based drug delivery and controlled release system using intraperitoneal macrophages as a cellular vehicle. Cancer Res. 66 (2006) 8740-8748
55. Howard K.A., Rahbek U.L., Liu X., Damgaard C.K., Glud S.Z., Andersen M.O., Hovgaard M.B., Schmitz A., Nyengaard J.R., Besenbacher F., and Kjems J. RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. Mol. Ther. 14 (2006) 476-484
56. Ogra P., Lamm M.E., Mcghee J.R., Mestecky J., Strober W., and Bienenstock J. Handbook of Mucosal Immunology (1994)
57. Tamura S., and Kurata T. Defense mechanisms against influenza virus infection in the respiratory tract mucosa. Jpn. J. Infect. Dis. 57 (2004) 236-247
58. Bitko V., Musiyenko A., Shulyayeva O., and Barik S. Inhibition of respiratory viruses by nasally administered siRNA. Nat. Med. 11 (2005) 50-55
59. Zhang X., Shan P., Jiang D., Noble P.W., Abraham N.G., Kappas A., and Lee P.J. Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis. J. Biol. Chem. 279 (2004) 10677-10684
60. Massaro D., Massaro G.D., and Clerch L.B. Noninvasive delivery of small inhibitory RNA and other reagents to pulmonary alveoli in mice. Am. J. Physiol. Lung. Cell. Mol. Physiol. 287 (2004) L1066-1070
61. Soane R.J., Frier M., Perkins A.C., Jones N.S., Davis S.S., and Illum L. Evaluation of the clearance characteristics of bioadhesive systems in humans. Int. J. Pharm. 178 (1999) 55-65
62. Artursson P., Lindmark T., Davis S.S., and Illum L. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm. Res. 11 (1994) 1358-1361
63. Kong X., Zhang W., Lockey R.F., Auais A., Piedimonte G., and Mohapatra S.S. Respiratory syncytial virus infection in Fischer 344 rats is attenuated by short interfering RNA against the RSV-NS1 gene. Genet. Vaccines Ther. 5 (2007) 4
64. Zhang W., Yang H., Kong X., Mohapatra S., San Juan-Vergara H., Hellermann G., Behera S., Singam R., Lockey R.F., and Mohapatra S.S. Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat. Med. 11 (2005) 56-62
65. Andersen M.O., Howard K.A., Paludan S.R., Besenbacher F., and Kjems J. Delivery of siRNA from lyophilized polymeric surfaces. Biomaterials 29 (2008) 506-512
66. Mislick K.A., and Baldeschwieler J.D. Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 12349-12354
67. Meade B.R., and Dowdy S.F. Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides. Adv. Drug Deliv. Rev. 60 (2008) 530-536
68. Simeoni F., Morris M.C., Heitz F., and Divita G. Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucleic Acids Res. 31 (2003) 2717-2724
69. Crombez L., Charnet A., Morris M.C., Aldrian-Herrada G., Heitz F., and Divita G. A non-covalent peptide-based strategy for siRNA delivery. Biochem. Soc. Trans. 35 (2007) 44-46
70. Veldhoen S., Laufer S.D., Trampe A., and Restle T. Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effect. Nucleic Acids Res. 34 (2006) 6561-6573
71. Kim W.J., Christensen L.V., Jo S., Yockman J.W., Jeong J.H., Kim Y.H., and Kim S.W. Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma. Mol. Ther. 14 (2006) 343-350
72. Kim S.H., Mok H., Jeong J.H., Kim S.W., and Park T.G. Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate. Bioconjug. Chem. 17 (2006) 241-244
73. Kim S.H., Jeong J.H., Lee S.H., Kim S.W., and Park T.G. LHRH receptor-mediated delivery of siRNA using polyelectrolyte complex micelles self-assembled from siRNA-PEG-LHRH conjugate and PEI. Bioconjug. Chem. 19 (2008) 2156-2162
74. Jiang G., Park K., Kim J., Kim K.S., Oh E.J., Kang H., Han S.E., Oh Y.K., Park T.G., and Kwang Hahn S. Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA. Biopolymers 89 (2008) 635-642
75. Oishi M., Nagasaki Y., Itaka K., Nishiyama N., and Kataoka K. Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile beta-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells. J. Am. Chem. Soc. 127 (2005) 1624-1625
76. Kim D.H., Behlke M.A., Rose S.D., Chang M.S., Choi S., and Rossi J.J. Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat. Biotechnol. 23 (2005) 222-226
77. Lee Y., Jeon K., Lee J.T., Kim S., and Kim V.N. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 21 (2002) 4663-4670
78. Morris K.V., Chan S.W., Jacobsen S.E., and Looney D.J. Small interfering RNA-induced transcriptional gene silencing in human cells. Science 305 (2004) 1289-1292
79. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., and Behr J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 7297-7301
80. Breunig M., Hozsa C., Lungwitz U., Watanabe K., Umeda I., Kato H., and Goepferich A. Mechanistic investigation of poly(ethylene imine)-based siRNA delivery: disulfide bonds boost intracellular release of the cargo. J. Control. Release 130 (2008) 57-63
81. Huang M., Fong C.W., Khor E., and Lim L.Y. Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation. J. Control Release. 106 (2005) 391-406
82. Ishii T., Okahata Y., and Sato T. Mechanism of cell transfection with plasmid/chitosan complexes. Biochim. Biophys. Acta 1514 (2001) 51-64
83. Zhou J., Wu J., Hafdi N., Behr J.P., Erbacher P., and Peng L. PAMAM dendrimers for efficient siRNA delivery and potent gene silencing. Chem. Commun. (Camb). (2006) 2362-2364
84. Convertine A.J., Benoit D.S., Duvall C.L., Hoffman A.S., and Stayton P.S. Development of a novel endosomolytic diblock copolymer for siRNA delivery. J. Control. Release 133 (2009) 221-229
85. Kwon E.J., Bergen J.M., and Pun S.H. Application of an HIV gp41-derived peptide for enhanced intracellular trafficking of synthetic gene and siRNA delivery vehicles. Bioconjug. Chem. 19 (2008) 920-927
86. Meyer M., Philipp A., Oskuee R., Schmidt C., and Wagner E. Breathing life into polycations: functionalization with pH-responsive endosomolytic peptides and polyethylene glycol enables siRNA delivery. J. Am. Chem. Soc. 130 (2008) 3272-3273
87. Lee S.H., Choi S.H., Kim S.H., and Park T.G. Thermally sensitive cationic polymer nanocapsules for specific cytosolic delivery and efficient gene silencing of siRNA: swelling induced physical disruption of endosome by cold shock. J. Control. Release 125 (2008) 25-32
88. He L., and Hannon G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5 (2004) 522-531
89. Rahbek U.L., Howard K.A., Oupicky D., Manickam D.S., Dong M., Nielsen A.F., Hansen T.B., Besenbacher F., and Kjems J. Intracellular siRNA and precursor miRNA trafficking using bioresponsive copolypeptides. J. Gene. Med. 10 (2008) 81-93
90. Boden D., Pusch O., Silbermann R., Lee F., Tucker L., and Ramratnam B. Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins. Nucleic Acids Res. 32 (2004) 1154-1158
91. Read M.L., Logan A., and Seymour L.W. Barriers to gene delivery using synthetic vectors. Adv. Genet. 53 (2005) 19-46
92. Bellomo G., Vairetti M., Stivala L., Mirabelli F., Richelmi P., and Orrenius S. Demonstration of nuclear compartmentalization of glutathione in hepatocytes. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 4412-4416
93. Hoon Jeong J., Christensen L.V., Yockman J.W., Zhong Z., Engbersen J.F., Jong Kim W., Feijen J., and Wan Kim S. Reducible poly(amido ethylenimine) directed to enhance RNA interference. Biomaterials 28 (2007) 1912-1917
94. Shim M.S., and Kwon Y.J. Controlled delivery of plasmid DNA and siRNA to intracellular targets using ketalized polyethylenimine. Biomacromolecules. 9 (2008) 444-455
95. Shim M.S., and Kwon Y.J. Controlled cytoplasmic and nuclear localization of plasmid DNA and siRNA by differentially tailored polyethylenimine. J. Control. Release 133 (2009) 206-213
96. Howard K.A., Dong M., Oupicky D., Bisht H.S., Buss C., Besenbacher F., and Kjems J. Nanocarrier stimuli-activated gene delivery. Small 3 (2007) 54-57
97. Lv H., Zhang S., Wang B., Cui S., and Yan J. Toxicity of cationic lipids and cationic polymers in gene delivery. J. Control. Release 114 (2006) 100-109
98. Patil M.L., Zhang M., Betigeri S., Taratula O., He H., and Minko T. Surface-modified and internally cationic polyamidoamine dendrimers for efficient siRNA delivery. Bioconjug. Chem. 19 (2008) 1396-1403
99. Akhtar S., and Benter I. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity. Adv. Drug. Deliv. Rev. 59 (2007) 164-182
100. Marques J.T., Devosse T., Wang D., Zamanian-Daryoush M., Serbinowski P., Hartmann R., Fujita T., Behlke M.A., and Williams B.R. A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat. Biotechnol. 24 (2006) 559-565
101. Judge A.D., Bola G., Lee A.C., and Maclachlan I. Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. Mol. Ther. 13 (2006) 494-505
102. Collingwood M.A., Rose S.D., Huang L., Hillier C., Amarzguioui M., Wiiger M.T., Soifer H.S., Rossi J.J., and Behlke M.A. Chemical modification patterns compatible with high potency Dicer-substrate small interfering RNAs. Oligonucleotides (2008)
103. Bonnet M.E., Erbacher P., and Bolcato-Bellemin A.L. Systemic delivery of DNA or siRNA mediated by linear polyethylenimine (L-PEI) does not induce an inflammatory response. Pharm. Res. 25 (2008) 2972-2982